GLP-1 Drug Shortages and Compounding July 2024 IPD has released a new podcast episode, GLP-1 Drug Shortages and Compounding," where Alyssa Guest, PharmD, discusses the glucagon-like peptide-1 (GLP-1) drugs and how interest in weight loss, viral social media posts, celebrity endorsements, illegitimate compounding, and drug shortages have all impacted access to GLP-1s
Doctors may recommend a diet chart to follow correctly
You have 14 days from the date your tracking link was sent to notify us of an undelivered or lost package, or damaged medication
Key Allegations Against Novo Nordisk The crux of these lawsuits lies in allegations that Novo Nordisk, the manufacturer of Ozempic, was remiss in warning users about potential severe side effects, which include: Gastroparesis Concerns : Often termed stomach paralysis lawsuits, these claims assert that users were not adequately warned about the risk of delayed stomach emptying, a condition known as gastroparesis
Eli Lilly was not caught entirely off guard